Julien Kirchgesner

5.1k total citations · 2 hit papers
59 papers, 1.9k citations indexed

About

Julien Kirchgesner is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Julien Kirchgesner has authored 59 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Genetics, 35 papers in Epidemiology and 19 papers in Surgery. Recurrent topics in Julien Kirchgesner's work include Inflammatory Bowel Disease (42 papers), Microscopic Colitis (31 papers) and Eosinophilic Esophagitis (10 papers). Julien Kirchgesner is often cited by papers focused on Inflammatory Bowel Disease (42 papers), Microscopic Colitis (31 papers) and Eosinophilic Esophagitis (10 papers). Julien Kirchgesner collaborates with scholars based in France, United States and Denmark. Julien Kirchgesner's co-authors include Fabrice Carrat, Franck Carbonnel, Laurent Beaugerie, Mahmoud Zureik, Rosemary Dray‐Spira, Magali Lemaître, A. Rudnichi, Tine Jess, Nynne Nyboe Andersen and Jean‐François Rahier and has published in prestigious journals such as JAMA, Gastroenterology and PLoS ONE.

In The Last Decade

Julien Kirchgesner

53 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

2017 388 citations Julien Kirchgesner, Fabrice Carrat et al. profile →
Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases

2018 372 citations Julien Kirchgesner, Fabrice Carrat et al. profile →

Peers

Countries citing papers authored by Julien Kirchgesner

Since Specialization

Citations

This map shows the geographic impact of Julien Kirchgesner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Kirchgesner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Kirchgesner more than expected).

Fields of papers citing papers by Julien Kirchgesner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Kirchgesner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Kirchgesner. The network helps show where Julien Kirchgesner may publish in the future.

Co-authorship network of co-authors of Julien Kirchgesner

This figure shows the co-authorship network connecting the top 25 collaborators of Julien Kirchgesner. A scholar is included among the top collaborators of Julien Kirchgesner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julien Kirchgesner. Julien Kirchgesner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ECCO Topical Review on Predictive Models on Inflammatory Bowel Disease Disease Course and Treatment Response 2025 ·Journal of Crohn s and Colitis ·Julien Kirchgesner, Bram Verstockt, Michel Adamina, Kristine H. Allin, Mariangela Allocca, Arno R. Bourgonje, Johan Burisch, Glen Doherty, Parambir S. Dulai, Alaa El‐Hussuna, Ravi Misra, Nurulamin M Noor, Valérie Pittet, Nick Powell, Iago Rodríguez–Lago, Sophie Restellini	2
2	Effectiveness and Safety of Advanced Dual‐Targeted Therapy in Refractory Perianal Crohn's Disease 2025 ·United European Gastroenterology Journal ·Nadia Fathallah, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Stéphane Morisset, Julien Kirchgesner, Vincent de Parades	1
3	Faecalibacterium Diversity in the Gut Microbiome of Crohn's Disease Patients 2025 ·United European Gastroenterology Journal ·(unknown), Sandrine Auger, (unknown), Loïc Brot, Nicolas Benech, Jean-Pierre Grill, Anne Bourrier, Denis Mariat, Camille Mayeur, Muriel Thomas, Véronique Robert, Julien Kirchgesner, Laurent Beaugerie, Harry Sokol, Philippe Langella, Philippe Seksik, Jean‐Marc Chatel	1
4	DOP26 Metagenomic and metabolomic profiles in IBD: understanding microbial and metabolic shifts from a large deeply phenotyped cohort 2024 ·Journal of Crohn s and Colitis ·(unknown), Nathalie Rolhion, (unknown), Antoine Lefèvre, (unknown), Loïc Brot, Camille Danne, Anne Bourrier, (unknown), Mélanie Dieudé, Nicolas Benech, Isabelle Nion–Larmurier, (unknown), Cécilia Landman, Laurent Beaugerie, Philippe Seksik, Patrick Emond, Julien Kirchgesner, Harry Sokol	1
5	Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened Patients 2024 ·Inflammatory Bowel Diseases ·Mathieu Uzzan, (unknown), Laurent Peyrin‐Biroulet, Yoram Bouhnik, Neeraj Narula, Vipul Jairath, Ryan C. Ungaro, Johan Burisch, Julien Kirchgesner, (unknown), (unknown), Walter Reinisch	2
6	A methodological review of the high-dimensional propensity score in comparative-effectiveness and safety-of-interventions research finds incomplete reporting relative to algorithm development and robustness 2024 ·Journal of Clinical Epidemiology ·(unknown), (unknown), Julian M. Rozenberg, Noémie Simon‐Tillaux, David Hajage, Julien Kirchgesner, Florence Tubach, Louis Létinier, Agnès Dechartres	1
7	Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study 2024 ·Alimentary Pharmacology & Therapeutics ·(unknown), Julien Kirchgesner, Mathieu Uzzan, (unknown), Carmen Stéfanescu, Jérémie H. Lefèvre, Xavier Tréton, Yves Panís, Harry Sokol, Laurent Beaugerie, (unknown), (unknown)	0
8	Drug Repurposing in Crohn’s Disease Using Danish Real-World Data 2024 ·PubMed ·(unknown), Kristine H. Allin, Tine Jess, María Antonietta Barbieri, Vera Battini, (unknown), Julien Kirchgesner, Trond Ulven, Maurizio Sessa	2
9	Focal loss of mural stratification as a radiological predictor for small bowel adenocarcinoma in Crohn's disease 2023 ·Clinics and Research in Hepatology and Gastroenterology ·Mathieu Uzzan, (unknown), (unknown), (unknown), Lionel Arrivé, Cécile Charpy, Alain Luciani, Iradj Sobhani, Aymeric Becq, Laurent Beaugerie, Magali Svrcek, Julien Kirchgesner	1
10	Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post‐inflammatory polyps 2023 ·Alimentary Pharmacology & Therapeutics ·Thomas Wolf, Ayanna Lewis, Laurent Beaugerie, Magali Svrcek, Julien Kirchgesner, (unknown)	5
11	Risk of Recurrent Acute Arterial Events Associated With Thiopurines and Anti-Tumor Necrosis Factor in Inflammatory Bowel Diseases 2022 ·Clinical Gastroenterology and Hepatology ·(unknown), (unknown), Laurent Beaugerie, Tine Jess, Julien Kirchgesner	10
12	Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort 2021 ·Alimentary Pharmacology & Therapeutics ·Mathieu Uzzan, (unknown), David Laharie, Carmen Stefănescu, (unknown), Franck Carbonnel, Mélanie Serrero, Stéphanie Viennot, Maria Nachury, Aurélien Amiot, Romain Altwegg, Laurence Picon, Stéphane Nahon, Lucine Vuitton, (unknown), Julien Kirchgesner, Laurent Peyrin‐Biroulet, Yoram Bouhnik, (unknown)	36
13	Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy 2021 ·Pharmacoepidemiology and Drug Safety ·Julien Kirchgesner, Rishi Desai, Maria C. Schneeweiss, Laurent Beaugerie, Seoyoung C. Kim, Sebastian Schneeweiß	8
14	Prospective evaluation of third-generation small bowel capsule endoscopy videos by independent readers demonstrates poor reproducibility of cleanliness classifications 2021 ·Clinics and Research in Hepatology and Gastroenterology ·Xavier Dray, (unknown), (unknown), Jean‐Christophe Saurin, Geoffroy Vanbiervliet, Chloé Leandri, Gabriel Rahmi, Clotilde Duburque, Julien Kirchgesner, Romain Leenhardt, Franck Cholet, Lucille Quénéhervé	12
15	Chronic pouchitis and Crohn's disease of the pouch after ileal pouch-anal anastomosis: Incidence and risk factors 2021 ·Digestive and Liver Disease ·(unknown), Aurélien Amiot, Julien Kirchgesner, Nicola de’Angelis, Jérémie H. Lefèvre, Yoram Bouhnik, Yves Panís, Laurent Beaugerie, Matthieu Allez, Antoine Brouquet, Franck Carbonnel, Antoine Meyer	14
16	The impact of body composition parameters on severe toxicity of nivolumab 2019 ·European Journal of Cancer ·Laure Hirsch, Audrey Bellesœur, Pascaline Boudou‐Rouquette, Jennifer Arrondeau, Audrey Thomas‐Schoemann, Julien Kirchgesner, Claire Gervais, Anne Jouinot, Jeanne Chapron, Frédérique Giraud, Marie Wislez, Jérôme Alexandre, Benoı̂t Blanchet, François Goldwasser	33
17	Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study 2019 ·Gut ·Julien Kirchgesner, Nynne Nyboe Andersen, Fabrice Carrat, Tine Jess, Laurent Beaugerie	56
18	Balancing Benefit vs Risk of Immunosuppressive Therapy for Individual Patients With Inflammatory Bowel Diseases 2018 ·Clinical Gastroenterology and Hepatology ·Laurent Beaugerie, Julien Kirchgesner	55
19	Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease 2018 ·PLoS ONE ·Guillaume Le Gall, Julien Kirchgesner, (unknown), Cécilia Landman, Isabelle Nion–Larmurier, Anne Bourrier, Harry Sokol, Philippe Seksik, Laurent Beaugerie	38
20	Antioxidant trace elements serum levels in long-term parenteral nutrition (PN): Prevalence and infectious risk associated with deficiencies, a retrospective study from a tertiary home-PN center 2016 ·Clinical Nutrition ·Mathieu Uzzan, Julien Kirchgesner, Joël Poupon, Olivier Corcos, (unknown), Francisca Joly	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact